Published on in Vol 5, No 2 (2016): Apr-Jun

Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial

Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial

Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial

Journals

  1. Carman A, Sautter C, Anyanwu J, Ssemata A, Opoka R, Ware R, Rujumba J, John C. Perceived benefits and risks of participation in a clinical trial for Ugandan children with sickle cell anemia. Pediatric Blood & Cancer 2020;67(2) View
  2. Power-Hays A, Ware R. Effective use of hydroxyurea for sickle cell anemia in low-resource countries. Current Opinion in Hematology 2020;27(3):172 View
  3. Green N, Munube D, Bangirana P, Buluma L, Kebirungi B, Opoka R, Mupere E, Kasirye P, Kiguli S, Birabwa A, Kawooya M, Lubowa S, Sekibira R, Kayongo E, Hume H, Elkind M, Peng W, Li G, Rosano C, LaRussa P, Minja F, Boehme A, Idro R. Burden of neurological and neurocognitive impairment in pediatric sickle cell anemia in Uganda (BRAIN SAFE): a cross-sectional study. BMC Pediatrics 2019;19(1) View
  4. Smart L, Hernandez A, Ware R. Sickle cell disease: Translating clinical care to low-resource countries through international research collaborations. Seminars in Hematology 2018;55(2):102 View
  5. Ware R, de Montalembert M, Tshilolo L, Abboud M. Sickle cell disease. The Lancet 2017;390(10091):311 View
  6. Epting C, Emmer B, Du N, Taylor J, Makanji M, Olson C, Engman D, Weiss L, Docampo R, Tanowitz H. Cell Cycle Inhibition To Treat Sleeping Sickness. mBio 2017;8(5) View
  7. McGann P, Hernandez A, Ware R. Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research. Blood 2017;129(2):155 View
  8. Opoka R, Ndugwa C, Latham T, Lane A, Hume H, Kasirye P, Hodges J, Ware R, John C. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia. Blood 2017;130(24):2585 View
  9. Nevitt S, Jones A, Howard J. Hydroxyurea (hydroxycarbamide) for sickle cell disease. Cochrane Database of Systematic Reviews 2017;2017(4) View
  10. John C, Opoka R, Latham T, Hume H, Nabaggala C, Kasirye P, Ndugwa C, Lane A, Ware R. Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa. New England Journal of Medicine 2020;382(26):2524 View
  11. Nartey E, Spector J, Adu-Afarwuah S, Jones C, Jackson A, Ohemeng A, Shah R, Koryo-Dabrah A, Kuma A, Hyacinth H, Steiner-Asiedu M. Nutritional perspectives on sickle cell disease in Africa: a systematic review. BMC Nutrition 2021;7(1) View

Books/Policy Documents

  1. Anderson C, Darbari D. Sickle Cell Disease and Hematopoietic Stem Cell Transplantation. View